Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Novartis Licenses Biomaterial for Cancer Immunotherapy

Drug maker Novartis is licensing from a lab at Harvard University a biocompatible material designed to provide delivery of treatments that invoke the immune system to fight cancer. . . . → Read More: Novartis Licenses Biomaterial for Cancer Immunotherapy

Evotec Acquiring Sanofi Infectious Disease Portfolio

Drug discovery company Evotec AG is licensing 10 infectious disease R&D programs and their 100 employees from drug maker Sanofi, and opening new labs for this work in Lyon, France. . . . → Read More: Evotec Acquiring Sanofi Infectious Disease Portfolio

Company Formed to Develop Cancer Cell Therapies

The MD Anderson Cancer Center in Houston is starting Optera Therapeutics Corp., a new company to commercialize its research on treating cancer with a patients’ own immune system cells. . . . → Read More: Company Formed to Develop Cancer Cell Therapies

Start-Up Developing Blood-Brain Barrier Treatments

A medical school professor in Singapore is starting a biotechnology company to discover and develop new drugs for neurological disorders based on his research with mechanisms for crossing the blood-brain barrier. . . . → Read More: Start-Up Developing Blood-Brain Barrier Treatments

Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal

Voyager Therapeutics, a developer of gene therapies for neurological disorders, is collaborating with drug maker AbbVie on treatments for diseases resulting from the build-up of damaging proteins in the brain, as in Alzheimer’s disease. . . . → Read More: Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal

Patents Awarded for Genetic Editing of CAR T-Cells

U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells. . . . → Read More: Patents Awarded for Genetic Editing of CAR T-Cells

Securing Your Small Business’s Profit

Unfortunately, if you don’t take the right steps, others will be able to directly copy your work and profit from it and there won’t be a whole lot that you can do. . . . → Read More: Securing Your Small Business’s Profit

Biotechs Collaborate on Immunotherapies in $1.2B Deal

Two biotechnology companies developing cancer therapies harnessing the immune system are partnering on new treatments for solid tumor and blood-related cancers. . . . → Read More: Biotechs Collaborate on Immunotherapies in $1.2B Deal

Neuro Therapy Company Spins-Off, Gains $20.8M Funding

A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors. . . . → Read More: Neuro Therapy Company Spins-Off, Gains $20.8M Funding

Biotech, Univ. Lab Partner on Stem Cells for Alzheimer’s

A biotechnology company specializing in stem cell therapeutics is licensing a process from Texas A&M University to produce exosomes — cellular delivery packages — from adult stem cells as possible therapies for Alzheimer’s disease. . . . → Read More: Biotech, Univ. Lab Partner on Stem Cells for Alzheimer’s